Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial

Lok Lam Ngai; Diana Hanekamp; Fleur Janssen; Jannemieke Carbaat-Ham; Maaike A. M. A. Hofland; Mona M. H. E. Fayed; Angèle Kelder; Laura Oudshoorn-van Marsbergen; Willemijn J. Scholten; Alexander N. Snel; C Bachas; Jesse M. Tettero; Dimitri A. Breems; Thomas Fischer; Bjørn T. Gjertsen; Laimonas Griškevičius; Gunnar Juliusson; Arjan A. van de Loosdrecht; Johan A. Maertens; Markus G. Manz; Thomas Pabst; Jakob R. Passweg; Kimmo Porkka; Peter J. M. Valk; Patrycja Gradowska; Bob Löwenberg; David C. de Leeuw; Jeroen J. W. M. Janssen; Gert J. Ossenkoppele; Jacqueline Cloos

doi:https://doi.org/10.1182/blood.2022019160

Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial

Lok Lam Ngai, Diana Hanekamp, Fleur Janssen, Jannemieke Carbaat-Ham, Maaike A. M. A. Hofland, Mona M. H. E. Fayed, Angèle Kelder, Laura Oudshoorn-van Marsbergen, Willemijn J. Scholten, Alexander N. Snel, C Bachas, Jesse M. Tettero, Dimitri A. Breems, Thomas Fischer, Bjørn T. Gjertsen, Laimonas Griškevičius, Gunnar Juliusson, Arjan A. van de Loosdrecht, Johan A. Maertens, Markus G. ManzThomas Pabst, Jakob R. Passweg, Kimmo Porkka, Peter J. M. Valk, Patrycja Gradowska, Bob Löwenberg, David C. de Leeuw, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	2657-2661
Number of pages	5
Journal	Blood
Volume	141
Issue number	21
Early online date	2023
DOIs	https://doi.org/10.1182/blood.2022019160 https://doi.org/10.1182/blood.2022019160
Publication status	Published - 25 May 2023

Access to Document

Cite this

Ngai, L. L., Hanekamp, D., Janssen, F., Carbaat-Ham, J., Hofland, M. A. M. A., Fayed, M. M. H. E., Kelder, A., Oudshoorn-van Marsbergen, L., Scholten, W. J., Snel, A. N., Bachas, C., Tettero, J. M., Breems, D. A., Fischer, T., Gjertsen, B. T., Griškevičius, L., Juliusson, G., van de Loosdrecht, A. A., Maertens, J. A., ... Cloos, J. (2023). Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial. Blood, 141(21), 2657-2661. https://doi.org/10.1182/blood.2022019160, https://doi.org/10.1182/blood.2022019160

@article{de51578d9fc34e96a0eb5fa13e84c55d,

title = "Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial",

author = "Ngai, {Lok Lam} and Diana Hanekamp and Fleur Janssen and Jannemieke Carbaat-Ham and Hofland, {Maaike A. M. A.} and Fayed, {Mona M. H. E.} and Ang{\`e}le Kelder and {Oudshoorn-van Marsbergen}, Laura and Scholten, {Willemijn J.} and Snel, {Alexander N.} and C Bachas and Tettero, {Jesse M.} and Breems, {Dimitri A.} and Thomas Fischer and Gjertsen, {Bj{\o}rn T.} and Laimonas Gri{\v s}kevi{\v c}ius and Gunnar Juliusson and {van de Loosdrecht}, {Arjan A.} and Maertens, {Johan A.} and Manz, {Markus G.} and Thomas Pabst and Passweg, {Jakob R.} and Kimmo Porkka and Valk, {Peter J. M.} and Patrycja Gradowska and Bob L{\"o}wenberg and {de Leeuw}, {David C.} and Janssen, {Jeroen J. W. M.} and Ossenkoppele, {Gert J.} and Jacqueline Cloos",

note = "Funding Information: This research was funded by the Dutch Cancer Society grant number ALPE-2013-6371.",

year = "2023",

month = may,

day = "25",

doi = "https://doi.org/10.1182/blood.2022019160",

language = "English",

volume = "141",

pages = "2657--2661",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "21",

}

Ngai, LL, Hanekamp, D, Janssen, F, Carbaat-Ham, J, Hofland, MAMA, Fayed, MMHE, Kelder, A, Oudshoorn-van Marsbergen, L, Scholten, WJ, Snel, AN, Bachas, C , Tettero, JM, Breems, DA, Fischer, T, Gjertsen, BT, Griškevičius, L, Juliusson, G, van de Loosdrecht, AA, Maertens, JA, Manz, MG, Pabst, T, Passweg, JR, Porkka, K, Valk, PJM, Gradowska, P, Löwenberg, B, de Leeuw, DC , Janssen, JJWM , Ossenkoppele, GJ & Cloos, J 2023, 'Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial', Blood, vol. 141, no. 21, pp. 2657-2661. https://doi.org/10.1182/blood.2022019160, https://doi.org/10.1182/blood.2022019160

TY - JOUR

T1 - Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial

AU - Ngai, Lok Lam

AU - Hanekamp, Diana

AU - Janssen, Fleur

AU - Carbaat-Ham, Jannemieke

AU - Hofland, Maaike A. M. A.

AU - Fayed, Mona M. H. E.

AU - Kelder, Angèle

AU - Oudshoorn-van Marsbergen, Laura

AU - Scholten, Willemijn J.

AU - Snel, Alexander N.

AU - Bachas, C

AU - Tettero, Jesse M.

AU - Breems, Dimitri A.

AU - Fischer, Thomas

AU - Gjertsen, Bjørn T.

AU - Griškevičius, Laimonas

AU - Juliusson, Gunnar

AU - van de Loosdrecht, Arjan A.

AU - Maertens, Johan A.

AU - Manz, Markus G.

AU - Pabst, Thomas

AU - Passweg, Jakob R.

AU - Porkka, Kimmo

AU - Valk, Peter J. M.

AU - Gradowska, Patrycja

AU - Löwenberg, Bob

AU - de Leeuw, David C.

AU - Janssen, Jeroen J. W. M.

AU - Ossenkoppele, Gert J.

AU - Cloos, Jacqueline

N1 - Funding Information: This research was funded by the Dutch Cancer Society grant number ALPE-2013-6371.

PY - 2023/5/25

Y1 - 2023/5/25

UR - http://www.scopus.com/inward/record.url?scp=85153517243&partnerID=8YFLogxK

U2 - https://doi.org/10.1182/blood.2022019160

DO - https://doi.org/10.1182/blood.2022019160

M3 - Article

C2 - 36898087

SN - 0006-4971

VL - 141

SP - 2657

EP - 2661

JO - Blood

JF - Blood

IS - 21

ER -

Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial

Access to Document

Other files and links

Cite this